Nugenerex Immuno-oncology, Inc. Current Liabilities
Nugenerex Immuno-oncology, Inc. had Current Liabilities of $13.72 million as of 2021-04-30, per its 10-Q filed 2021-06-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2021-06-14
- 2021-04-30: Liabilities, Current $13.72M.
- 2021-01-31: Liabilities, Current $8.41M.
- 2020-10-31: Liabilities, Current $6.03M.
- 2020-07-31: Liabilities, Current $5.84M.
| Period end | Liabilities, Current |
|---|---|
| 2021-04-30 | $13.72M 10-Q · filed 2021-06-14 |
| 2021-01-31 | $8.41M 10-Q · filed 2021-03-12 |
| 2020-10-31 | $6.03M 10-Q · filed 2020-12-15 |
| 2020-07-31 | $5.84M 10-Q · filed 2021-06-14 |
| 2020-04-30 | $5.40M 10-Q · filed 2020-06-19 |
| 2020-01-31 | $5.13M 10-Q · filed 2020-06-17 |
| 2019-07-31 | $4.38M 10-K · filed 2020-10-29 |